Literature DB >> 11820878

Molecular design and biological potential of galacto-type trehalose as a nonnatural ligand of shiga toxins.

Hirofumi Dohi1, Yoshihiro Nishida, Yuki Furuta, Hirotaka Uzawa, Shin-ichiro Yokoyama, Saori Ito, Hiroshi Mori, Kazukiyo Kobayashi.   

Abstract

Galacto-type trehalose, a "C-4 epimer of trehalose", possesses a stereochemical structure around the alpha(1-1)-linkage analogous to that of the globobiosyl alpha(1-4)-linkage in Gb(2) and Gb(3) ceramides, which are known as the ligands of Shiga toxins produced by pathogenic E. coli. This paper presents evidence supporting the new idea of using a trehalosyl alpha(1-1)-linkage as a substitute for the galactobiosyl alpha(1-4)-linkage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820878     DOI: 10.1021/ol017135+

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.

Authors:  D E Akiyoshi; C M Rich; S O'Sullivan-Murphy; L Richard; J Dilo; A Donohue-Rolfe; A S Sheoran; S Chapman-Bonofiglio; S Tzipori
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants.

Authors:  Abhineet S Sheoran; Susan Chapman; Pradeep Singh; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

3.  Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases.

Authors:  Paola Neri; Shunji Tokoro; Ryo Kobayashi; Tsuyoshi Sugiyama; Kouji Umeda; Takeshi Shimizu; Takao Tsuji; Yoshikatsu Kodama; Keiji Oguma; Hiroshi Mori
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

Review 4.  Trehalose Analogues: Latest Insights in Properties and Biocatalytic Production.

Authors:  Maarten Walmagh; Renfei Zhao; Tom Desmet
Journal:  Int J Mol Sci       Date:  2015-06-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.